Email: info@neweastbio.com   |  Call: 6109452007

VLDLR Rabbit pAb

Anti-VLDLR Rabbit Polyclonal Antibody
5/5

$349.00

Cat.#:  S221104

   Size:   100 μl

In Stock

          Product Description          
Cat.#:   S221104
Product Name:   Anti-VLDLR Rabbit Polyclonal Antibody
Synonyms:   CARMQ1; CHRMQ1; VLDLRCH
UNIPROT ID:   P98155 (Gene Accession – NP_003374 )
Background:    The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR-associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants encoding distinct isoforms for this gene.
Immunogen:    Synthetic peptide of human VLDLR
Applications:    ELISA, IHC
Recommended Dilutions:    IHC: 25-100; ELISA: 2000-5000
Host Species:    Rabbit
Clonality:    Rabbit Polyclonal
Isotype:    Immunogen-specific rabbit IgG
Purification:    Antigen affinity purification
Species Reactivity:    Human, Mouse, Rat
Constituents:    PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.05% Sodium Azide and 40% glycerol
Research Areas:    Metabolism, Signal Transduction, Cancer, Cardiovascular, Neuroscience
Storage & Shipping:    Store at -20°C. Avoid repeated freezing and thawing

Immunohistochemistry analysis of paraffin embedded Human liver cancer tissue using 221104(VLDLR Antibody) at a dilution of 1/35(Cytoplasm).

In comparision with the IHC on the left, the same paraffin-embedded Human liver cancer tissue is first treated with the synthetic peptide and then with 221104(Anti-VLDLR Antibody) at dilution 1/35.

The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using 221104(Anti-VLDLR Antibody) at a dilution of 1/35.

In comparision with the IHC on the left, the same paraffin-embedded Human thyroid cancer tissue is first treated with synthetic peptide and then with D262480(Anti-VLDLR Antibody) at dilution 1/35.
          Publications